What is China Shineway Pharmaceutical Group Pretax Margin %?
China Shineway Pharmaceutical GroupCSWYF 92 Pretax Margin % is 33.36% as of Dec. 2025, which is 25% above its 10-year median of 26.75. GuruFocus rates CSWYF with a GF Score™ of 92/100 and a GF Value™ of $0.88. The stock has 2 warning signs investors should review. Among 955 Drug Manufacturers companies, China Shineway Pharmaceutical Group ranks better than 96.13% on this metric.
CSWYF'
s Pretax Margin % Range Over the Past 10 Years
Min: 14.87 Med: 26.75 Max: 40.48
Current: 40.45
CSWYF's Pretax Margin % is ranked better than 96.13% of 955
companies
in the Drug Manufacturers industry
Industry Median: 7.28
vs CSWYF: 40.45
China Shineway Pharmaceutical Group (OTCPK:CSWYF) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
China Shineway Pharmaceutical Group Pretax Margin % Related Terms
China Shineway Pharmaceutical Group Pretax Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Shineway Pharmaceutical Group Pretax Margin % Chart
For the Drug Manufacturers - Specialty & Generic subindustry, China Shineway Pharmaceutical Group's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Shineway Pharmaceutical Group Pretax Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, China Shineway Pharmaceutical Group's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where China Shineway Pharmaceutical Group's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Shineway Pharmaceutical Group (CSWYF) has a Pretax Margin % of 33.36% as of Dec. 2025. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on China Shineway Pharmaceutical Group and its competitors. This is 25% above median its historical median of 26.75. Over the past decade, China Shineway Pharmaceutical Group's Pretax Margin % has ranged from 14.87 to 40.48. According to the industry distribution chart, China Shineway Pharmaceutical Group ranks #37 out of 955 companies in the Drug Manufacturers industry, placing it in the top 3.9%.
Is China Shineway Pharmaceutical Group's Pretax Margin % too high?
China Shineway Pharmaceutical Group's current Pretax Margin % of 33.36% is 25% above median its 10-year median of 26.75. Over the past 10 years, this metric has ranged from a low of 14.87 to a high of 40.48. The Drug Manufacturers industry median Pretax Margin % is 7.28. China Shineway Pharmaceutical Group's value of 33.36% is 358.2% above this industry median. Based on the distribution chart, China Shineway Pharmaceutical Group ranks #37 out of 955 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, China Shineway Pharmaceutical Group has a GF Score™ of 92/100, reflecting its overall financial health beyond just this single metric.
How does China Shineway Pharmaceutical Group's Pretax Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, China Shineway Pharmaceutical Group ranks #37 out of 955 companies for Pretax Margin %. This places China Shineway Pharmaceutical Group in the top 4% of its industry — outperforming the majority of peers. The industry median Pretax Margin % is 7.28. China Shineway Pharmaceutical Group's value of 33.36% is 358.2% above this benchmark. Historically, China Shineway Pharmaceutical Group's own Pretax Margin % has ranged from 14.87 to 40.48 over the past decade. While the company's 10-year median is 26.75 vs. the industry median of 7.28, China Shineway Pharmaceutical Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Drug Manufacturers company?
The median Pretax Margin % among Drug Manufacturers companies is 7.28, based on 955 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. China Shineway Pharmaceutical Group's current Pretax Margin % of 33.36% is 358.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on China Shineway Pharmaceutical Group and its competitors. For the Drug Manufacturers industry, the median Pretax Margin % is 7.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China Shineway Pharmaceutical Group's current Pretax Margin % is 33.36%, which is 25% above median its own 10-year median of 26.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Shineway Pharmaceutical Group stock overvalued right now?
China Shineway Pharmaceutical Group (CSWYF) has a current Pretax Margin % of 33.36%. The stock's GF Value™ is $0.88, compared to a current price of $1.00 — trading 14.1% above its estimated fair value. The current Pretax Margin % is 33.36%, which is 25% above median its 10-year median of 26.75 and 358.2% above the Drug Manufacturers industry median of 7.28. China Shineway Pharmaceutical Group's overall GF Score™ is 92/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For China Shineway Pharmaceutical Group (CSWYF), the current Pretax Margin % is 33.36% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is China Shineway Pharmaceutical Group (CSWYF) Overvalued in 2026?
Based on GuruFocus' analysis, China Shineway Pharmaceutical Group stock appears to be overvalued.
The current stock price of $1.00 is trading 14.1% above its estimated GF Value™ of $0.88.
Key valuation signals for CSWYF:
Pretax Margin %: 33.36% (25% above median its 10-year median of 26.75)
GF Value™: $0.88 vs. price of $1.00 (14.1% above fair value)
Industry Position: 358.2% above the Drug Manufacturers median (#37 of 955)
No single metric tells the full story. See the CSWYF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
China Shineway Pharmaceutical Group Business Description
China Shineway Pharmaceutical Group Ltd is an investment holding company. Along with its subsidiaries, it is engaged in the research, development, manufacturing, and trading of modern Chinese medicines. The company's products comprise injection, soft capsule, granule, traditional Chinese medicine formula granules, and others, of which injections generate maximum revenue for the company. Geographically, the group operates in the People's Republic of China (PRC) and Hong Kong.
92GF Score
Get the complete analysis for CSWYF
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CSWYF has been successfully added to your 
